1. Home
  2. ICUI vs SGRY Comparison

ICUI vs SGRY Comparison

Compare ICUI & SGRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICUI
  • SGRY
  • Stock Information
  • Founded
  • ICUI 1984
  • SGRY 2004
  • Country
  • ICUI United States
  • SGRY United States
  • Employees
  • ICUI N/A
  • SGRY N/A
  • Industry
  • ICUI Medical/Dental Instruments
  • SGRY Hospital/Nursing Management
  • Sector
  • ICUI Health Care
  • SGRY Health Care
  • Exchange
  • ICUI Nasdaq
  • SGRY Nasdaq
  • Market Cap
  • ICUI 3.2B
  • SGRY 2.8B
  • IPO Year
  • ICUI 1992
  • SGRY 2015
  • Fundamental
  • Price
  • ICUI $140.16
  • SGRY $21.70
  • Analyst Decision
  • ICUI Buy
  • SGRY Buy
  • Analyst Count
  • ICUI 6
  • SGRY 7
  • Target Price
  • ICUI $183.60
  • SGRY $31.14
  • AVG Volume (30 Days)
  • ICUI 290.1K
  • SGRY 1.0M
  • Earning Date
  • ICUI 11-06-2025
  • SGRY 11-10-2025
  • Dividend Yield
  • ICUI N/A
  • SGRY N/A
  • EPS Growth
  • ICUI N/A
  • SGRY N/A
  • EPS
  • ICUI N/A
  • SGRY N/A
  • Revenue
  • ICUI $2,320,363,000.00
  • SGRY $3,237,000,000.00
  • Revenue This Year
  • ICUI N/A
  • SGRY $9.78
  • Revenue Next Year
  • ICUI N/A
  • SGRY $9.59
  • P/E Ratio
  • ICUI N/A
  • SGRY N/A
  • Revenue Growth
  • ICUI N/A
  • SGRY 12.05
  • 52 Week Low
  • ICUI $107.00
  • SGRY $18.87
  • 52 Week High
  • ICUI $196.26
  • SGRY $31.89
  • Technical
  • Relative Strength Index (RSI)
  • ICUI 73.86
  • SGRY 44.93
  • Support Level
  • ICUI $116.21
  • SGRY $21.19
  • Resistance Level
  • ICUI $120.60
  • SGRY $22.29
  • Average True Range (ATR)
  • ICUI 4.88
  • SGRY 0.72
  • MACD
  • ICUI 1.92
  • SGRY -0.03
  • Stochastic Oscillator
  • ICUI 69.73
  • SGRY 21.32

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (43% of consolidated revenue), infusion systems (28%), and vital care (29%). The combined entity remains primarily US-focused, generating over 63% of its sales domestically.

About SGRY Surgery Partners Inc.

Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It has one reportable segment: Surgical Facilities which includes the operation of ASCs, surgical hospitals, anesthesia services, and multi-specialty physician practices, which earns revenues from contracts with patients in which the performance obligations are to provide health care services.

Share on Social Networks: